Decapeptyl 0.1 MG

Decapeptyl

Showing all 3 results

  • Decapeptyl 0.1 MG

    Decapeptyl 0.1 mg, powder for suspension for injection.

    1 disposable syringe with 1 ml solution for injection contains 105 µg triptorelin acetate, corresponding to 95.6 µg triptorelin.

    Quick View
  • Decapeptyl 11.25MG

    Therapeutic indications
    Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
    Treatment of metastatic prostate cancer.
    As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
    As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
    As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
    Treatment of endometriosis.
    Treatment of precocious puberty (onset before 8 years in girls and 10 years in boys).

    Link: Decapeptyl

    Quick View
  • Decapeptyl 3.75MG

    Decapeptyl SR 3 mg, powder for suspension for injection.

    Triptorelin (I.N.N.) 4.2 mg, as triptorelin acetate.
    The vial contains an overage to ensure that a dose of 3 mg is administered to the patient.

    Link : Decapeptyl

    Quick View
X